References
- Hughes RS, Frenkel EP. The role of chemotherapy in head and neck cancer. Am J Clin Oncol 1997; 20: 449–69.
- Anderson N, Lokich J. Controversial issues in 5-fluorouracil infusion use. Cancer 1992; 70: 998–1002.
- Lokich JJ, Ahlgren JD, Gullo JJ, et al. A prospective ran-domized comparison of continuous infusion fluorouracil with conventional bolus schedule in metastatic colorectal car-cinoma: a mid-Atlantic oncology program study. J Clin Oncol 1989; 7: 425–32.
- Huan S, Pazdur R, Singhakowinta A, et al. Low-dose contin-uous infusion 5-fluorouracil. Evaluation in advanced breast carcinoma. Cancer 1989; 63: 419–22.
- Caballero GA, Ausman RK, Quebbeman EJ. Long-term am-bulatory, continuous IV infusion of 5-FU for the treatment of advanced adenocarcinomas. Cancer Treat Rep 1985; 69: 13–5.
- Lokich JJ, Shea M, Chaffey J. Sequential infusional 5-fluorouracil followed by concomitant radiation for tumors of the esophagus and gastroesophageal junction. Cancer 1987; 60: 275–9.
- WHO-handbook for reporting results of cancer treatments. WHO offset publication No. 48. Geneva: WHO, 1979.
- Kaplan EL, Meier P. Nonparametric estimation from incom-plete observations. J Am Statist Assoc 1958; 53: 457–81.
- Al-Sarraf M. Head and neck cancer: chemotherapy concepts. Semin Oncol 1988; 15: 70–85.
- Browman GP, Cronin L. Standard chemotherapy in squamous cell head and neck cancer: What we have learned from randomized trials? Semin Oncol 1994; 3: 311–9.
- Vokes EE, Haraf DJ, Weichselbaum RR, et al. Perspectives on combination chemotherapy with concomitant radiother-apy for poor-prognosis head and neck cancer. Semin Oncol 1992; 19: 47–56.
- Schilsky RL. Biochemical pharmacology of chemotherapeutic drugs used as radiation enhancers. Semin Oncol 1992; 19: 2–7.